Whole-body magnetic resonance angiography

Abstract

Vascular disease, whether it be atherosclerosis, inflammatory, or hereditary vasculitide, is a systemic disorder with disease in one territory predictive of disease in another. Despite this, current approaches focus on single-territory assessment ignoring the global burden of disease. Advances in MRI have enabled us to surmount previous limitations and expand our approach to such conditions with the ability to simultaneously assess the entirety of the arterial tree in a single examination, allowing a staging examination as it were, of the vascular health in its totality. This review will cover the acquisition technique, reporting, clinical utility, and current evidence base for such an approach.

Unveiling the next generation of MRI contrast agents: current insights and perspectives on ferumoxytol-enhanced MRI

“…First, ferumoxytol offers multiple advantages, including a proven safety profile, a one-stop-shop protocol for high-resolution imaging of multiple vascular beds, and intravenous iron supplementation, which all boost the forward progress of patient-specific care. Given that vascular diseases often affect multiple vascular beds [ 107 ], utilizing ferumoxytol for one-stop whole-body multivessel bed assessment in patients with coexisting vascular disease is extremely beneficial, especially for patients with diabetes and cardiovascular disease. As the venous system has garnered increased attention in recent years, a more comprehensive assessment of multiple vessel beds will provide more thorough diagnostic information in various cases.…”